MaxCyte Inc

Healthcare · Medical Devices

1.00$ -4.6% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

MaxCyte Inc (MXCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 185 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MXCT
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	16	16	37	37	31	31	27	27	24	24	25	25	30	30	–	53	–	52	95	93	278	284	291	290	286	287	282	271	267	268	258	251	249	239	230	220	213	203	194	185
Current Assets	16	16	37	37	31	31	26	26	22	22	22	22	24	24	17	47	45	45	88	85	270	270	266	258	252	252	246	237	214	190	179	176	173	172	156	143	125	118	123	121
Cash	12	12	30	30	25	25	16	16	11	11	11	11	15	15	-17	38	–	19	79	37	59	48	240	109	43	11	38	55	49	47	22	38	37	28	23	15	13	20	15	15
Cash & Short-Term Investments	12	12	30	30	25	25	19	19	14	14	15	15	17	17	17	38	–	35	79	73	256	255	246	241	233	227	225	216	190	168	158	157	154	154	138	127	106	103	15	106
Receivables	2.4	2.4	3.7	3.7	3.2	3.2	3.8	3.8	4.9	4.9	2.8	2.8	3.2	3.2	–	3.7	5.2	5.2	4.3	5.7	6.0	6.9	11	7.9	7.4	11	9.3	7.6	8.2	5.8	6.0	4.6	4.6	4.7	5.5	5.8	8.3	3.5	4.2	3.9
Inventory	1.3	1.3	1.5	1.5	1.3	1.3	2.0	2.0	2.2	2.2	3.5	3.5	3.7	3.7	4.2	4.2	4.3	4.3	4.5	4.2	4.1	5.2	6.6	7.7	7.9	8.6	10	11	13	12	12	11	10	8.9	8.3	7.9	7.6	7.5	7.6	7.8
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	6.4	–	6.5	6.5	6.5	6.8	7.8	13	13	31	23	24	25	24	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3.9	3.7	3.6	–	–	–
Intangible Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.5	0.6	0.7	0.7	0.8	0.8
Total Liabilities	11	11	12	12	12	12	11	11	12	12	8.4	8.7	16	16	–	16	–	19	14	14	14	21	29	33	32	33	34	30	33	36	32	30	35	33	31	29	33	31	27	26
Current Liabilities	5.7	5.7	6.8	6.8	6.4	7.2	5.8	5.8	6.6	6.6	8.4	8.4	9.3	9.3	9.2	9.2	12	12	11	13	13	16	16	18	17	15	17	13	17	18	13	12	18	16	13	12	16	14	10	9.9
Short-Term Debt	0.0	0.0	0.0	0.0	0.0	0.9	–	2.8	–	2.4	0.3	–	0.5	0.5	–	0.5	–	0.7	0.7	0.6	0.6	0.5	0.5	0.4	0.2	0.2	0.5	0.5	0.7	0.8	0.8	0.9	0.9	0.9	1.3	1.3	1.3	1.5	1.4	1.5
Accounts Payable	3.2	3.2	3.2	3.2	4.3	4.3	3.0	3.0	1.0	4.1	4.3	4.3	2.1	2.1	–	0.7	0.9	0.9	0.4	0.6	0.7	1.8	4.4	2.5	2.1	0.3	3.5	1.6	0.4	0.7	1.7	1.0	1.9	1.4	2.3	1.2	1.3	1.4	1.2	1.7
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	4.9	–	4.9	–	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	5.1	5.1	25	25	20	20	15	15	12	12	16	16	14	14	14	37	–	33	81	79	264	263	262	257	254	254	248	241	233	232	226	221	213	206	199	191	180	171	168	159
Retained Earnings	-52	-52	-56	-56	-62	-62	-66	-66	-71	-71	-80	-80	-83	-83	–	-89	-95	-95	-102	-107	-109	-114	-118	-127	-133	-138	-149	-159	-171	-176	-185	-195	-206	-217	-227	-239	-252	-261	-266	-275
Shares Outstanding	44	44	46	46	51	51	51	51	51	51	55	55	57	57	57	66	77	77	81	85	96	101	101	101	102	102	103	103	103	104	104	105	105	105	106	106	106	106	107	107

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings